Latest Cancer News

Calquence Improves Survival in Relapsed Chronic Lymphocytic Leukemia (05-20-2019)
An interim analyses of the phase 3 “ASCEND” clinical trial evaluating single-agent Calquence (acalabrutinib) compared to Rituxan (rituximab) plus idelasib or bendamustine in recurrent chronic lymphocytic... Continue Reading

Zytig Treatment Prolongs Survival in Advanced Prostate Cancer (05-7-2019)
Zytig (Abiraterone acetate) plus prednisone and androgen deprivation therapy (ADT) significantly extends overall survival compared with placebo plus ADT in men with newly diagnosed high-risk metastatic... Continue Reading

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation (05-7-2019)
On May 2, 2019, the Food and Drug Administration approved ivosidenib (TIBSOVO, Agios Pharmaceuticals, Inc.) for newly-diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation, as detected... Continue Reading

More Cancer News

Locations

Louisiana Hematology Oncology Associates
Main Office:
4950 Essen Lane, Ste 500
Baton Rouge, LA 70809
Phone: (225) 767-1311
Fax: (225) 767-1335
Louisiana Hematology Oncology Associates
Satellite Offices:
Woman’s Hospital
9000 Airline Hwy.
Suite 290
Baton Rouge, LA 70815
Phone: (225)767-1311
Gonzales
1104 W. Hwy 30
Gonzales, LA 70737
Phone: (225) 215-1547

Zachary
4753 W. Park Dr.
Zachary, LA 70809
Phone: (225) 658-8779